Compare SERA & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SERA | SABA |
|---|---|---|
| Founded | 2008 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.6M | 240.1M |
| IPO Year | 2021 | N/A |
| Metric | SERA | SABA |
|---|---|---|
| Price | $3.01 | $8.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.7K | ★ 290.0K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $95,000.00 | N/A |
| Revenue This Year | $19.22 | N/A |
| Revenue Next Year | $400.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.06 | N/A |
| 52 Week Low | $1.37 | $3.64 |
| 52 Week High | $9.13 | $4.42 |
| Indicator | SERA | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 51.30 |
| Support Level | $2.81 | $8.61 |
| Resistance Level | $3.30 | $8.86 |
| Average True Range (ATR) | 0.26 | 0.15 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 36.00 | 69.36 |
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.